Common misconceptions

Common mistake
Wrong: Affinity chromatography separates proteins based on size or charge, like other chromatography methods.
Right: Affinity chromatography exploits a specific, reversible biological interaction (e.g., enzyme-substrate, antibody-antigen, His-tag/Ni-NTA) to selectively capture one target from a complex mixture.
Affinity chromatography doesn't care about a protein's size or net charge — it cares whether that protein has a specific molecular partner on the resin. A His-tagged protein binds Ni-NTA because histidine coordinates nickel; an untagged protein of the same size and charge flows straight through. This is what makes affinity chromatography so powerful: you can go from crude cell lysate to near-pure protein in a single step, something size- or charge-based methods can't achieve alone.
Common mistake
Wrong: Increasing salt concentration is the standard way to elute a His-tagged protein from a Ni-NTA affinity column.
Right: His-tagged proteins are eluted from Ni-NTA columns with imidazole, which competes with the histidine residues for nickel coordination sites.
Salt gradients elute proteins in ion exchange chromatography by disrupting electrostatic interactions — that logic doesn't transfer to His-tag purification. In Ni-NTA affinity chromatography, the histidine-nickel interaction is a coordinate covalent bond, not an ionic interaction. Imidazole (which shares the same ring structure as the histidine side chain) competes directly for the nickel coordination sites, displacing your tagged protein. High salt does essentially nothing to break that coordination bond.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the core principle: the stationary phase carries a specific ligand, and only the target protein binds — selectivity comes from biospecific molecular recognition, not size or charge.
  2. Know the elution strategies for different affinity systems: imidazole competition for His-tag/Ni-NTA, pH changes to disrupt ionic or hydrogen-bond interactions, and denaturants as a last resort — and be able to choose the right strategy for a given scenario.
  3. Apply affinity chromatography logic to novel passage contexts — such as antibody-antigen or enzyme-substrate analog systems — to predict which fraction contains the target protein and what experimental steps would release it.

Can you avoid these mistakes?

A researcher runs a His-tagged enzyme through a Ni-NTA column, washes with buffer, then elutes with 250 mM NaCl. She gets almost nothing in the elution fraction. What went wrong, and what should she use instead?
You're designing an affinity purification scheme for a protein that binds ATP. What would you use as the stationary phase ligand, and how would you elute your target protein once it's bound?
How does affinity chromatography differ fundamentally from ion exchange chromatography? If you had a pure sample of a negatively charged protein and ran it through both an anion exchange column and an affinity column with an unrelated ligand, what would happen in each case?
A passage describes purifying an antibody by running serum over a column packed with its target antigen immobilized on resin. The antibody binds at pH 7.4 but is released at pH 2.5. What does this tell you about the nature of the antibody-antigen interaction, and why does lowering pH cause elution?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →